Plenary Session 2103

Ataxia Therapies: What Works, What's New, and What's Next?

Saturday, February 14, 2026
8:00 - 9:45 | Houston Ballroom

In this session, the faculty will present an overview of the current state of ataxia treatment, and explore proven symptomatic and rehabilitative therapies; promising disease-modifying strategies under investigation; and future directions, including gene therapy, biomarkers, and personalized interventions. Attendees will gain practical insights and a forward-looking perspective on managing ataxia in both clinical and research settings.

Chairs:

Orlando Barsottini, Brazil
Malco Rossi, Argentina

Presenters:

What Works for Ataxia: Optimizing Care Today
José Luiz Pedroso, Brazil

What’s New for Ataxia

What’s Next in Ataxia Care: Innovations and Future Technologies
Christopher Stephen, USA

CSPC Liaisons:

Mario Cornejo-Olivas, Peru

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Analyze effective symptomatic and supportive therapies currently used in ataxia management.
2. Recognize the landscape of emerging disease-modifying treatments for ataxia through late-stage clinical trials.
3. Discuss upcoming innovative gene therapy approaches and future technologies in the development of therapies for ataxia.

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level

Beginner / Foundational
Experienced
Expert